# AarogyaDamu Project 3 — P0.7.7 Final Verification & Independent Audit Report

**Phase:** P0.7.7 — Final Verification & Independent Audit (P0.7 Agentic Execution Closeout)  
**Date:** 2026-11-03  
**Auditor:** Antigravity Autonomous Clinical & Systems Security Auditor  
**Scope:** Comprehensive verification of P0.7.1 through P0.7.6 implementation, security architecture, clinical governance, test suites, and deployment boundaries.  
**Verdict:** **PASS — P0.7 ENGINEERING VERIFICATION COMPLETE**

---

## 1. Executive Summary

Phase **P0.7 — Governed Agentic Execution** was authorized to provide AarogyaDamu with deterministic, safe, and transparent AI agent planning and action execution for diabetes self-management. P0.7 introduces bounded natural-language action proposal generation, human-in-the-loop (HITL) patient confirmation, doctor-in-the-loop clinical review, and idempotent execution against allowlisted clinical and care tasks.

This final audit independently verified the end-to-end implementation across all sub-phases:
- **P0.7.1**: Contracts, State Machine, Tool Allowlist & Clinical Prohibitions
- **P0.7.2**: Persistence Schema (AgentPlan, AgentAction, AgentAuditRecord), Indexes & Foreign Keys
- **P0.7.3**: Agent Runtime Proposal Engine, Emergency Halts & Idempotent Tool Execution
- **P0.7.4**: Governed REST API Endpoints, Zod Validation, RBAC & IDOR Protections
- **P0.7.5**: Mobile UI Companion & Proposal Cards (React Native / Expo)
- **P0.7.6**: Doctor Dashboard Workstation Proposal Review & Action Activity Feed (React / Vite)

All 480 automated regression tests passed with zero failures across the monorepo. Type checks and production builds for Web and API succeeded without error.

**Readiness Segmentation:**
- **P0.7 Engineering Completion:** **COMPLETE (PASS)**
- **Clinician Demo Readiness:** **READY (Feature-flag gated)**
- **Controlled Pilot Readiness:** **CONDITIONAL (Requires Redis for multi-node rate limiting and background expiry cron)**
- **Production Deployment Readiness:** **NOT READY (Pending P0.8 External Integrations, real-device audio validation, and medical device regulatory certification)**

---

## 2. Repository State & Commit Baseline

- **Current Git Branch:** `cleanup-checkpoint`
- **HEAD Commit Hash:** `5c80ead23deb05f2aa791f56f5af1ce7c8ceea84`
- **Baseline Integrity:** Matches the exact baseline reported by the P0.7.6 post-remediation audit.
- **Working Tree:** All tracked modifications and untracked files created during P0.0–P0.7 have been preserved. No uncommitted user work was overwritten or discarded.
- **Deployment Boundaries:**
  - `P0_7_AGENTIC_EXECUTION = false` (verified default in `services/api/src/config/env.ts`)
  - `P0_8_EXTERNAL_INTEGRATIONS = false` (verified default in `services/api/src/config/env.ts`)
  - `Clinical Governance = PENDING_CLINICIAN_APPROVAL` strictly maintained.

---

## 3. P0.7.1–P0.7.6 Sub-Phase Verification Matrix

| Sub-Phase | Component | Key Capabilities Verified | Test Status | Audit Status |
| :--- | :--- | :--- | :--- | :--- |
| **P0.7.1** | Contracts & Governance | Canonical state transitions, 6 allowlisted tools, risk tiers, prohibited clinical action refusal, caregiver permissions matrix. | 41/41 passing | **VERIFIED** |
| **P0.7.2** | Database & Persistence | Prisma models (`AgentPlan`, `AgentAction`), compound indexes, unique idempotency keys, atomic transaction creation. | 25/25 passing | **VERIFIED** |
| **P0.7.3** | Agent Runtime | Intent classifier, max 3 actions per plan, emergency halt on acute symptoms/hypo, tool executor, idempotency replay, crash recovery. | 76/76 passing | **VERIFIED** |
| **P0.7.4** | REST API Endpoints | 7 authenticated endpoints under `/api/agent`, Zod request validation, doctor-patient assignment checks, caregiver consent scoping. | 55/55 passing | **VERIFIED** |
| **P0.7.5** | Mobile UI Integration | Damu voice/chat Q&A separated from Governed Proposals, proposal cards, HITL confirm, UUID v4 idempotency, cancellation reason. | 24/24 passing | **VERIFIED** |
| **P0.7.6** | Doctor Dashboard UI | Proposal review feed, approve/reject workflow with rationale, non-mutation copy, modal accessibility, fallback target badge. | 29/29 passing | **VERIFIED** |

---

## 4. Complete Agent Lifecycle Verification

The governed agent execution lifecycle was verified across the full operational pipeline:

1. **User Request Ingestion:** User inputs natural language query (voice or text).
2. **Pre-Planning Safety & Emergency Precedence:** Runtime inspects query for acute red-flag symptoms (e.g. chest pain, fainting, seizure, difficulty swallowing) or glucose readings below 54 mg/dL. If detected, planning is aborted with `EMERGENCY_HALT` and 108/112 emergency instructions.
3. **Prohibited Intent Interception:** If user asks for medication prescription, insulin titration, or medical diagnosis, request is deterministically refused (`PROHIBITED_REFUSED`) without creating action proposals.
4. **Tool Allowlisting & Bounded Planning:** If benign, intent classifier selects among exactly 6 authorized tools (`tool_schedule_care_task`, `tool_schedule_reminder`, `tool_request_appointment`, `tool_log_lifestyle_record`, `tool_draft_care_proposal`, `tool_query_health_summary`). Actions per plan are strictly capped at 3.
5. **Persistence & Risk Attribution:** `AgentPlan` and `AgentAction` records are atomically written to SQLite/PostgreSQL with unique UUID idempotency keys and 24-hour expiration windows. Risk tier (`LOW_RISK`, `MEDIUM_RISK`, `HIGH_RISK`) is derived deterministically.
6. **Governance Routing:**
   - Patient-confirmable actions (`AWAITING_CONFIRMATION`): Rendered in mobile app for patient/caregiver confirmation.
   - Clinical proposal actions (`PENDING_CLINICIAN_APPROVAL`): Patient confirmation button is hidden; routed to Doctor Dashboard.
7. **Confirmation Gateway Execution:**
   - Identity, RBAC, caregiver consent, and active doctor-patient assignment re-validated.
   - Acute symptoms and hypoglycemia re-evaluated at confirmation time.
   - Conditional database update claims action (`EXECUTING`).
   - Strict Zod schema validates tool arguments.
   - Tool executor executes mutation against Prisma models (`Reminder`, `CareTask`, `Consultation`, `LifestyleRecord`).
   - If repeated with identical idempotency key, cached result returned (`replayed: true`).
8. **Clinical Review Gateway:**
   - Clinician reviews proposal in Doctor Dashboard.
   - Decision (`APPROVE` or `REJECT`) submitted with review notes / mandatory rationale.
   - Proposal approval marks action `COMPLETED` and creates an `AgentAuditRecord` (`CLINICAL_CARE_PROPOSAL`), but deliberately creates **zero** automatic mutations on `CarePlan` or `Prescription`.
9. **Status Transparency & Expiration:** Mobile and web interfaces reflect server-confirmed status. Stale proposals past 24 hours are blocked from execution.

---

## 5. Clinical Safety Assessment

The following non-negotiable safety guardrails are programmatically enforced:
- **No Autonomous Prescribing:** `PRESCRIBE_MEDICATION` is blocked by contract and planner.
- **No Autonomous Insulin Adjustment:** `ADJUST_INSULIN_DOSE` and `MODIFY_DOSAGE` are blocked.
- **No Autonomous Diagnosis:** `INDEPENDENT_DIAGNOSIS` is blocked.
- **No Automatic CarePlan/Medication Mutation on Proposal Approval:** Approving a care proposal only records clinician concurrence in the audit log; all care plan changes require direct doctor entry via standard clinical workflows.
- **Strict Aspiration Safety:** Spoken emergencies involving impaired consciousness or choking immediately block oral glucose recommendations.
- **Clinical Governance State:** `PENDING_CLINICIAN_APPROVAL` remains canonical across contracts, schemas, UI components, and API validation.

---

## 6. Security & Authorization Audit Findings

### Summary of Vulnerability Classifications:
- **CRITICAL:** 0
- **HIGH:** 0
- **MEDIUM:** 2 (Architectural limitations documented below)
- **LOW:** 2 (Deferred component testing & randomness fallback)
- **INFORMATIONAL:** 1 (Single continuous E2E test gap)

### Specific Findings:

#### 1. MED-P0.7.7-01: User Cascade-Delete Risk on Clinical Audit Provenance
- **Location:** `services/api/prisma/schema.prisma` lines 767–768, 800, 613
- **Analysis:** `AgentPlan.owner` and `AgentPlan.targetPatient` relations define `onDelete: Cascade`. If a caregiver or clinician account is removed, all plans authored by that actor are cascade-deleted, potentially purging audit history and action records for the target patient.
- **Healthcare Standard:** Clinical provenance standards (DISHA / HIPAA) require audit records and historical care actions to remain immutable and preserved (`onDelete: Restrict` or soft-deletion).
- **Remediation Recommendation:** Before production deployment, update foreign keys to `onDelete: Restrict` or implement a soft-delete architecture (`deletedAt`) for `User` records.

#### 2. MED-P0.7.7-02: Absence of Production Background Worker for Stale Expiry Sweeps
- **Location:** `services/api/src/ai/agent/agentRuntime.ts` (`expireStalePlansAndActions`)
- **Analysis:** The runtime contains logic to expire proposals older than 24 hours and recover abandoned `EXECUTING` actions. However, this function is only invoked during tests; no active background scheduler (e.g. BullMQ, node-cron, or cloud worker) is configured in `server.ts`.
- **Operational Impact:** While actions past expiration are safely blocked from execution at confirmation time (`isActionExecutable`), unconfirmed proposals will linger in database queries and dashboard feeds until a sweep occurs.
- **Remediation Recommendation:** Configure a periodic background job (e.g., every 15 minutes) in the deployment infrastructure to sweep expired records.

#### 3. LOW-P0.7.7-03: Web Component Testing Deferred to Harness Unification
- **Location:** `apps/web/tests/`
- **Analysis:** Web tests currently utilize Node's native test runner (`node --import tsx --test tests`), static AST parsing, and mock API interaction suites. React DOM mounted tests via `@testing-library/react` and `jsdom` are not yet installed in `apps/web`.
- **Mitigation:** Comprehensive API interaction mocking and Vite production builds verify syntax, typing, and network contracts. Formally cataloged for test harness modernization.

#### 4. LOW-P0.7.7-04: Mobile UUID v4 Math.random Fallback
- **Location:** `apps/mobile/src/api/agent.ts` lines 85–94
- **Analysis:** `generateUUID()` uses `globalThis.crypto.randomUUID()` when available, but falls back to `Math.random()` on engines lacking crypto polyfills.
- **Remediation Recommendation:** In production React Native builds, install `expo-crypto` to guarantee cryptographically secure pseudo-random number generation across all legacy devices.

#### 5. INFO-P0.7.7-05: Absence of Single Cross-Product Monorepo End-to-End Test
- **Location:** Test infrastructure across `apps/` and `services/`
- **Analysis:** The 16-step agent lifecycle is rigorously covered across separate integration suites (`p0_7_4_agent_api.test.ts`, `agent-ui.test.cjs`, `doctor-proposals-api-interaction.test.mjs`). However, there is no single monolithic Playwright/Detox end-to-end test running the mobile app, doctor web portal, and backend server simultaneously in one test script.
- **Operational Status:** Acceptable for modular architecture; verified via API contract compatibility.

---

## 7. Database & Persistence Assessment

- **Prisma Models:** `AgentPlan` (15 fields) and `AgentAction` (18 fields) in `schema.prisma`.
- **Indexes:**
  - `AgentPlan`: `[userId, status]`, `[targetPatientId, status]`, `[status, expiresAt]`, `[createdAt]`, `[organizationId]`.
  - `AgentAction`: `[planId, status]`, `[status, expiresAt]`, `[toolName]`, `[confirmedByUserId]`, `[auditRecordId]`.
- **Concurrency & Idempotency:** `idempotencyKey` is marked `@unique`. Atomic database updates (`prisma.agentAction.updateMany({ where: { id, status: 'AWAITING_CONFIRMATION' }, data: { status: 'EXECUTING' } })`) prevent double-execution race conditions.
- **Data Integrity:** Validated across 25 persistence integration tests.

---

## 8. Mobile and Web Verification

### Mobile Agent Experience (`apps/mobile`):
- **Architecture:** Two-product architecture preserved; doctor-only routes excluded from mobile shell.
- **Damu Companion:** Q&A voice companion is clearly segregated from Governed Agent Proposals.
- **Proposal Cards:** Cards display tool name, formatted parameters, risk tier badge, and status.
- **Governance Gate:** Patient confirmation button is hidden for proposals in `PENDING_CLINICIAN_APPROVAL`.
- **Safety Interventions:** Emergency halts immediately display emergency disclaimers and 108/112 quick-dial.
- **Test Results:** 24/24 tests passed. Mobile typecheck clean (`tsc --noEmit`).

### Doctor Dashboard (`apps/web`):
- **Workstation View:** AI Care Proposals tab integrated into Doctor Command Center.
- **Proposal Review:** Displays pending clinical proposals with patient context drawer, vital trends, and medication history.
- **Approval Copy:** Explicitly clarifies that proposal approval does not mutate EHR records.
- **Rejection Workflow:** Requires documented clinical rationale (min 3 characters).
- **Accessibility:** All 3 modal dialogs include ARIA roles, focus trapping, Escape dismissal, and focus restoration.
- **Fallback Target Labeling:** Unrecorded patient targets display `"Reference Default — Not a Recorded Patient Target"` badge.
- **Test Results:** 29/29 tests passed. Production Vite build completed without errors.

---

## 9. Build and Test Evidence

| Workspace | Command | Suites | Tests Passed | Tests Failed | Exit Code | Build Artifacts |
| :--- | :--- | :--- | :--- | :--- | :--- | :--- |
| **`apps/web` (Tests)** | `npm test --prefix apps/web` | 2 | 29 | 0 | **0** | — |
| **`apps/web` (Build)** | `npm run build --prefix apps/web` | — | — | — | **0** | `dist/index.html` (0.77 kB), `dist/assets/*.js` (377 kB) |
| **`apps/mobile` (Tests)** | `npm test --prefix apps/mobile` | 2 | 24 | 0 | **0** | — |
| **`apps/mobile` (Typecheck)**| `npm run typecheck:mobile` | — | — | — | **0** | Validated zero TS errors |
| **`services/api` (Build)** | `npm run build --prefix services/api` | — | — | — | **0** | `dist/` compiled cleanly via `tsc` |
| **`services/api` (P0.7 API)** | `npm test --prefix services/api -- src/__tests__/p0_7_4_agent_api.test.ts` | 1 | 55 | 0 | **0** | SQLite in-memory test DB |
| **`services/api` (P0.7 Core)**| `npm test --prefix services/api -- src/__tests__/p0_7_1_agentic_contracts.test.ts ...` | 3 | 142 | 0 | **0** | SQLite in-memory test DB |
| **`services/api` (P0.6 Voice)**| `npm test --prefix services/api -- src/__tests__/p0_6_groq_voice_assistant.test.ts ...` | 2 | 38 | 0 | **0** | Live test skipped cleanly without API key |
| **`services/api` (P0.0-P0.5)** | `npm test --prefix services/api -- src/__tests__/p0_0_safety_foundation.test.ts ...` | 7 | 153 | 0 | **0** | Full historical safety regression |
| **`services/api` (Core Auth)** | `npm test --prefix services/api -- src/__tests__/security_regression.test.ts ...` | 4 | 39 | 0 | **0** | Token revocation, session rotation |
| **Root Monorepo** | `npm run build` | — | — | — | **0** | Root workspace build verified |

**Total Regression Test Metrics:**
- **Suites Executed:** 21 test suites
- **Total Tests Passed:** **480 tests passed**
- **Total Tests Failed:** **0 tests failed**
- **Total Tests Skipped:** 1 test (Live Groq call skipped as expected in local environment)

---

## 10. Outstanding Operational Blockers

1. **Multi-Node Rate Limiting (Redis Dependency):**
   - The API uses `createRateLimitStore`, which defaults to in-memory `MemoryStore` when Redis is not configured.
   - For multi-instance clustered production deployments, `RATE_LIMIT_STORE=redis` and `REDIS_URL` must be configured to prevent per-instance rate limit circumvention.
2. **Background Expiry Worker:**
   - As identified in MED-P0.7.7-02, a background scheduler must be deployed to invoke `expireStalePlansAndActions()` periodically.
3. **Database Deletion Semantics:**
   - Schema update required to transition `User` cascade deletes to `Restrict` / soft-delete for medical audit compliance.

---

## 11. Clinical & Regulatory Dependencies

Before clinical activation with real diabetic patients, the following external validations remain required:
- **Qualified Endocrinologist Review:** Formal institutional clinical review of prompt safety guidelines, emergency keyword thresholds, and target defaults.
- **Physical Audio Testing:** Real-device Android and iOS microphone hardware testing in noisy Indian ambient environments.
- **Indian Regional Language Validation:** Certified clinical translation review for Hindi, Marathi, Telugu, Tamil, and Bengali prompts.
- **Third-Party AI Governance:** HIPAA / DISHA business associate agreement and zero-retention contract verification with Groq / LLM inference providers.
- **Medical Device Software Classification:** Determination of SaMD (Software as a Medical Device) regulatory classification under Indian CDSCO / FDA guidelines.

---

## 12. Production-Readiness Assessment

```
┌─────────────────────────────────────────────────────────────────┐
│                    AAROGYADAMU P0.7 READINESS                    │
├─────────────────────────────────────────────────┬───────────────┤
│ Dimension                                       │ Status        │
├─────────────────────────────────────────────────┼───────────────┤
│ Core Engineering & Contracts                    │ PASS (100%)   │
│ Persistence & Concurrency Controls              │ PASS (100%)   │
│ Automated Regression Suite (480 tests)          │ PASS (100%)   │
│ Clinician Demonstration (Simulated Data)        │ READY         │
│ Controlled Clinic Pilot (Staging Environment)   │ CONDITIONAL   │
│ Production Real-Patient Deployment              │ NOT READY     │
└─────────────────────────────────────────────────┴───────────────┘
```

---

## 13. Final Recommendations

1. **Maintain Feature Flag Inactive:** Keep `P0_7_AGENTIC_EXECUTION = false` and `P0_8_EXTERNAL_INTEGRATIONS = false` until all deployment prerequisites are met.
2. **Proceed to Staging Demo:** P0.7 is fully verified and ready for controlled internal demonstrations to clinical stakeholders using synthetic patient data.
3. **Plan P0.8 External Integrations:** Ensure that any future external integrations (e.g. ABDM, FHIR, lab aggregators) preserve the governance boundaries established in P0.7.

---

## 14. Final Audit Verdict

### **VERDICT: PASS — P0.7 ENGINEERING VERIFICATION COMPLETE**

**Justification:** All 6 sub-phases of P0.7 (P0.7.1 through P0.7.6) have been completely implemented, verified, and audited. Every test suite across the monorepo passes with zero failures (480/480 tests), TypeScript compilation is clean across all packages, production bundles build successfully, and clinical governance boundaries (`PENDING_CLINICIAN_APPROVAL`) are rigorously enforced. Operational blockers and clinical regulatory dependencies are thoroughly documented.

---
*(Execution stopped per protocol. Phase P0.7 is complete. Awaiting explicit user authorization prior to proceeding to any subsequent phase.)*

